Literature DB >> 17465705

Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.

Jennifer M Fostel.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17465705     DOI: 10.2217/14622416.8.5.425

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  5 in total

Review 1.  Toxicogenetics: population-based testing of drug and chemical safety in mouse models.

Authors:  Ivan Rusyn; Daniel M Gatti; Timothy Wiltshire; Timothy Wilshire; Steven R Kleeberger; David W Threadgill
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

Review 2.  Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity.

Authors:  Alison Hege Harrill; Ivan Rusyn
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

3.  Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel.

Authors:  Alison H Harrill; Pamela K Ross; Daniel M Gatti; David W Threadgill; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2009-05-06       Impact factor: 4.849

4.  Heading down the wrong pathway: on the influence of correlation within gene sets.

Authors:  Daniel M Gatti; William T Barry; Andrew B Nobel; Ivan Rusyn; Fred A Wright
Journal:  BMC Genomics       Date:  2010-10-18       Impact factor: 3.969

5.  Systems Biology and Biomarkers of Early Effects for Occupational Exposure Limit Setting.

Authors:  D Gayle DeBord; Lyle Burgoon; Stephen W Edwards; Lynne T Haber; M Helen Kanitz; Eileen Kuempel; Russell S Thomas; Berran Yucesoy
Journal:  J Occup Environ Hyg       Date:  2015       Impact factor: 2.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.